7,919 results match your criteria: "Institute of Medical Microbiology[Affiliation]"
Open Forum Infect Dis
September 2024
Institute of Tropical Medicine, Universitätsklinikum Tübingen, Tübingen, Germany.
Int J Mol Sci
September 2024
Institute of Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, 1090 Vienna, Austria.
The demand for terrestrial snails as a food source is still on the increase globally, yet this has been overlooked in disease epidemiology and the spread of antimicrobial resistance. This study conducted genomic analyses of twenty strains isolated from live edible snails traded in two hubs. The isolates were subjected to MALDI-TOF MS, antimicrobial resistance testing, whole genome sequencing, and analyses for in-depth characterization.
View Article and Find Full Text PDFAntibiotics (Basel)
September 2024
Department of Neurosurgery and Neurointervention, Semmelweis University, 1083 Budapest, Hungary.
A carbapenem-resistant (CRAB) outbreak in an intensive care unit (ICU) was contained by an improved infection-control measure that included a disinfectant policy. In our retrospective cohort study, we describe the epidemiological investigations and infection-control measures during this outbreak. Descriptive analysis was used to summarize patient demographics, neurological diseases, surgical treatment, underlying diseases, infection, and outcomes.
View Article and Find Full Text PDFBMC Bioinformatics
September 2024
Friedrich Loeffler-Institute of Medical Microbiology-Virology, University Medicine Greifswald, 17475, Greifswald, Germany.
Background: Antigen presentation is a central step in initiating and shaping the adaptive immune response. To activate CD8 T cells, pathogen-derived peptides are presented on the cell surface of antigen-presenting cells bound to major histocompatibility complex (MHC) class I molecules. CD8 T cells that recognize these complexes with their T cell receptor are activated and ideally eliminate infected cells.
View Article and Find Full Text PDFPLoS One
September 2024
College of Veterinary Medicine, Western University of Health Sciences, Pomona, CA, United States of America.
In the present study, the presence of the Enterobacterales, Staphylococcus spp., Mammaliicoccus spp., and Enterococcus spp.
View Article and Find Full Text PDFEur J Clin Microbiol Infect Dis
December 2024
Department of Microbiological Reference Laboratories, National Center for Public Health and Pharmacy, Albert Flórián Rd. 2-6. 1097, Budapest, Hungary.
Gels
September 2024
Oral Technology, Dental School, Medical Faculty, University Hospital Bonn, 53111 Bonn, Germany.
Objectives: The study addresses the challenge of cross-infection in dentistry, focusing on improving disinfection protocols for dental hydrocolloid gel materials. This research aimed to incorporate chlorhexidine, natural plant extracts, and green-synthesized silver nanoparticles (AgNPs) into dental alginate to enhance safety and hygiene standards in dental practices.
Methods: Conventional dental alginate served as the control, with experimental groups including alginate modified with 0.
Cells
September 2024
Laboratório de Ultraestrutura Celular Hertha Meyer, Centro de Pesquisa em Medicina de Precisão, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Case Rep Infect Dis
September 2024
Department of Acute and Emergency Medicine University Hospital and University of Saarland, Homburg, Germany.
Nat Commun
September 2024
Clinical Bioinformatics, Saarland University, 66123, Saarbrücken, Germany.
The human microbiome emerges as a promising reservoir for diagnostic markers and therapeutics. Since host-associated microbiomes at various body sites differ and diseases do not occur in isolation, a comprehensive analysis strategy highlighting the full potential of microbiomes should include diverse specimen types and various diseases. To ensure robust data quality and comparability across specimen types and diseases, we employ standardized protocols to generate sequencing data from 1931 prospectively collected specimens, including from saliva, plaque, skin, throat, eye, and stool, with an average sequencing depth of 5.
View Article and Find Full Text PDFNat Commun
September 2024
Chair for Clinical Bioinformatics, Saarland University, 66123, Saarbrücken, Germany.
Understanding human, animal, and environmental microbiota is essential for advancing global health and combating antimicrobial resistance (AMR). We investigate the oral and gut microbiota of 48 animal species in captivity, comparing them to those of wildlife animals. Specifically, we characterize the microbiota composition, metabolic pathways, AMR genes, and biosynthetic gene clusters (BGCs) encoding the production of specialized metabolites.
View Article and Find Full Text PDFAnaerobe
December 2024
Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye; ESCMID Study Group for Anaerobic Infections (ESGAI), Basel, Switzerland. Electronic address:
Objectives: This study was conducted to measure the prevalence of antibiotic resistance, and corresponding resistance genes among Bacteroides and related genera in a tertiary hospital.
Methods: We examined 138 clinical strains of Bacteroides, Phocaeicola and Parabacteroides species isolated between July 2018 and June 2022. Antibiotic susceptibility tests were conducted using agar dilution.
Science
September 2024
Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Harnessing the microbiome to benefit human health requires an initial step in determining the identity and function of causative microorganisms that affect specific host physiological functions. We show a functional screen of the bacterial microbiota from mice with low intestinal immunoglobulin A (IgA) levels; we identified a Gram-negative bacterium, proposed as , that induces and degrades IgA in the mouse intestine. Mice harboring are susceptible to infections and show poor mucosal repair.
View Article and Find Full Text PDFAntimicrob Agents Chemother
November 2024
Division of Infectious Diseases, Infection Prevention and Travel Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.
The objective of this study was to determine the prevalence, molecular epidemiology, and risk factors for gut colonization with extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), carbapenemase-producing Enterobacterales (CPE), and vancomycin-resistant enterococci (VRE) in healthcare workers (HCWs). In September/October 2022, we performed a cross-sectional study among HCW from 14 institutions in Northeastern Switzerland. HCWs reported risk factors for antimicrobial resistance (covering the last 12-24 months) and provided rectal swabs.
View Article and Find Full Text PDFJ Clin Microbiol
October 2024
Gradientech AB, Uppsala, Sweden.
J Clin Periodontol
February 2025
Institute of Experimental and Clinical Pharmacology and Toxicology, PZMS, ZHMB, Saarland University, Homburg, Germany.
Aim: Periodontal disease is driven by oral pathogens, including Porphyromonas gingivalis, and the release of inflammatory cytokines. These cytokines (e.g.
View Article and Find Full Text PDFStroke
October 2024
Institute for Stroke and Dementia Research, Ludwig Maximilians University (LMU) University Hospital, LMU Munich, Germany (G.L., S. Heindl, A.R., A.L.).
Background: The discrepancy between experimental research and clinical trial outcomes is a persistent challenge in preclinical studies, particularly in stroke research. A possible factor contributing to this issue is the lack of standardization across experimental stroke models, leading to poor reproducibility in multicenter studies. This study addresses this gap by aiming to enhance reproducibility and the efficacy of multicenter studies through the harmonization of protocols and training of involved personnel.
View Article and Find Full Text PDFSTAR Protoc
September 2024
Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Philosophenweg 14, 07743 Jena, Germany; Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, Philosophenweg 7, 07743 Jena, Germany. Electronic address:
Here, we present a protocol for primary, human immune cell isolation and stimulation for lipid mediator profiling. We describe steps for the isolation of monocytes from human leukocyte concentrates via density centrifugation and differentiation/polarization toward M1- or M2-monocyte-derived macrophages (MDMs). We detail stimulation approaches of MDMs with live bacteria or influenza A virus for lipid mediator profiling and sample preparation for subsequent analysis, such as enzyme expression, mRNA analysis, or surface marker determination.
View Article and Find Full Text PDFAdv Healthc Mater
December 2024
Chair of Materials Science (CMS), Otto Schott Institute of Materials Research (OSIM), Friedrich Schiller University Jena, Löbdergraben 32, 07743, Jena, Germany.
Developing effective antimicrobial biomaterials is a relevant and fast-growing field in advanced healthcare materials. Several well-known (e.g.
View Article and Find Full Text PDFMed Microbiol Immunol
September 2024
Institute of Medical Microbiology, University of Münster, Domagkstraße 10, 48149, Münster, Germany.
The Panton-Valentine leukocidin (PVL) of Staphylococcus aureus is associated with necrotizing infections. After binding to complement 5a receptor (C5aR/CD88) and CD45 it causes cytolysis in polymorphonuclear neutrophils (PMNs) as well as inflammasome activation in monocytes. The objective of this study was to test if (ant)agonists of C5aR and CD45 can attenuate the effect of PVL on PMNs and monocytes.
View Article and Find Full Text PDFJ Med Chem
October 2024
Institute of Organic Chemistry, Universität Hamburg, Martin-Luther-King-Platz 6, 20146 Hamburg, Germany.
In a fragment-based approach using NMR spectroscopy, benzyloxyacetohydroxamic acid-derived inhibitors of the bacterial deacetylase LpxC bearing a substituent to target the uridine diphosphate-binding site of the enzyme were developed. By appending privileged fragments via a suitable linker, potent LpxC inhibitors with promising antibacterial activities could be obtained, like the one-digit nanomolar LpxC inhibitor ()- [ (LpxC C63A) = 9.5 nM; (LpxC): 5.
View Article and Find Full Text PDFTransplant Cell Ther
December 2024
Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany; Center for Integrated Oncology (CIO) ABCD, Aachen Bonn Cologne Düsseldorf, Germany. Electronic address:
Gut Microbes
September 2024
Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
J Med Microbiol
September 2024
Institute of Medical Microbiology, University Hospital Münster, Münster, Germany.
The European Committee on Antimicrobial Susceptibility Testing (EUCAST) specifies the agar depth (4±0.5 mm) when performing antimicrobial susceptibility testing (AST). Since the infrastructure to produce standardized agar may be lacking in settings with limited resources, we wanted to examine to what extent variation in agar depth affects the inhibition zone diameters of quality control (QC) strains and AST of clinical isolates.
View Article and Find Full Text PDFOpen Forum Infect Dis
September 2024
Institute of Infectious Diseases and Infection Control, Jena University Hospital/Friedrich-Schiller-University, Jena, Germany.
Virologic failure of long-acting rilpivirine/cabotegravir is rare but may result in severely limited treatment options. Known risk factors cannot predict all cases. Therapeutic drug monitoring (TDM) may help identify patients at risk, but reliable thresholds are missing.
View Article and Find Full Text PDF